UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM N-PX
ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY
Investment Company Act File number: 811-01528
Bruce Fund, Inc.
(Exact name of registrant as specified in charter)
20 North Wacker Drive, Suite 2414, Chicago, IL 60606
(Address of principal executive offices) (Zip code)
Robert B. Bruce
20 North Wacker Drive, Suite 2414
Chicago, Illinois 60606
(Name and address of agent for service)
Registrant’s telephone number, including area code: 312-236-9160
Date of fiscal year end: June 30
Date of reporting period: 07/01/2016-06/30/2017
Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (Secs. 239.24 and 274.5 of this chapter),to file reports with the Commission, not later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b 1-4).The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.
A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget C’OMB”) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. Sec. 3507.
| | | | | | | | | | | | | | | | |
Security Name | | Ticker | | Cusip | | Meeting Date | | Proposed (M) or (S) | | Description | | Did the Fund Vote? | | For, Against or Abstain | | For or Against Management |
| | | | | | | | |
EDAP | | EDAP | | 268311107 | | 6/30/2017 | | M | | Auditors | | Yes | | For | | For |
EDAP | | EDAP | | 268311107 | | 6/30/2017 | | M | | Financials | | Yes | | For | | For |
EDAP | | EDAP | | 268311107 | | 6/30/2017 | | M | | Allocation net loss | | Yes | | For | | For |
EDAP | | EDAP | | 268311107 | | 6/30/2017 | | M | | Directors | | Yes | | For | | For |
| | | | | | | | |
Astrotech | | ASTC | | 046484101 | | 12/9/2016 | | M | | Directors | | Yes | | For | | For |
Astrotech | | ASTC | | 046484101 | | 12/9/2016 | | M | | Auditors | | Yes | | For | | For |
| | | | | | | | |
Calpine | | CPN | | 131347304 | | 5/10/2017 | | M | | Directors | | Yes | | For | | For |
Calpine | | CPN | | 131347304 | | 5/10/2017 | | M | | Auditors | | Yes | | For | | For |
Calpine | | CPN | | 131347304 | | 5/10/2017 | | M | | Compensation | | Yes | | For | | For |
Calpine | | CPN | | 131347304 | | 5/10/2017 | | M | | Compensation Frequency | | Yes | | For | | For |
Calpine | | CPN | | 131347304 | | 5/10/2017 | | M | | Equity Incentive Plan | | Yes | | For | | For |
Calpine | | CPN | | 131347304 | | 5/10/2017 | | M | | Proxy Access | | Yes | | For | | For |
Calpine | | CPN | | 131347304 | | 5/10/2017 | | M | | Lobbying Report | | Yes | | For | | For |
| | | | | | | | |
Goldcorp | | GG | | 380956409 | | 4/26/2017 | | M | | Directors | | Yes | | For | | For |
Goldcorp | | GG | | 380956409 | | 4/26/2017 | | M | | Auditors | | Yes | | For | | For |
Goldcorp | | GG | | 380956409 | | 4/26/2017 | | M | | Compensation | | Yes | | For | | For |
| | | | | | | | |
Actua Corp. | | ACTA | | 005094107 | | 6/16/2017 | | M | | Directors | | Yes | | For | | For |
Actua Corp. | | ACTA | | 005094107 | | 6/16/2017 | | M | | Accounting | | Yes | | For | | For |
Actua Corp. | | ACTA | | 005094107 | | 6/16/2017 | | M | | Compensation | | Yes | | For | | For |
Actua Corp. | | ACTA | | 005094107 | | 6/16/2017 | | M | | Compensation Frequency | | Yes | | For | | For |
| | | | | | | | |
Bunge | | BG | | G16962105 | | 5/25/2017 | | M | | Directors | | Yes | | For | | For |
Bunge | | BG | | G16962105 | | 5/25/2017 | | M | | Accounting | | Yes | | For | | For |
Bunge | | BG | | G16962105 | | 5/25/2017 | | M | | Executive Compensation | | Yes | | For | | For |
Bunge | | BG | | G16962105 | | 5/25/2017 | | M | | Compensation Frequency | | Yes | | For | | For |
Bunge | | BG | | G16962105 | | 5/25/2017 | | M | | Equity Incentive Plan | | Yes | | For | | For |
| | | | | | | | |
Merck | | MRK | | 58933Y105 | | 5/23/2017 | | M | | Directors | | Yes | | For | | For |
Merck | | MRK | | 58933Y105 | | 5/23/2017 | | M | | Accounting | | Yes | | For | | For |
Merck | | MRK | | 58933Y105 | | 5/23/2017 | | M | | Compensation | | Yes | | For | | For |
Merck | | MRK | | 58933Y105 | | 5/23/2017 | | M | | Compensation Frequency | | Yes | | For | | For |
Merck | | MRK | | 58933Y105 | | 5/23/2017 | | S | | Conflict-Affected Areas | | Yes | | Against | | For |
| | | | | | | | | | | | | | | | |
Merck | | MRK | | 58933Y105 | | 5/23/2017 | | S | | Employee Practices | | Yes | | Against | | For |
Merck | | MRK | | 58933Y105 | | 5/23/2017 | | S | | Independent Chairman | | Yes | | Against | | For |
Merck | | MRK | | 58933Y105 | | 5/23/2017 | | S | | Product Safety | | Yes | | Against | | For |
| | | | | | | | |
IBM | | IBM | | 459200101 | | 4/25/2017 | | M | | Directors | | Yes | | For | | For |
IBM | | IBM | | 459200101 | | 4/25/2017 | | M | | Accounting | | Yes | | For | | For |
IBM | | IBM | | 459200101 | | 4/25/2017 | | M | | Compensation Frequency | | Yes | | For | | For |
IBM | | IBM | | 459200101 | | 4/25/2017 | | M | | Executive Compensation | | Yes | | For | | For |
IBM | | IBM | | 459200101 | | 4/25/2017 | | S | | Lobbying | | Yes | | For | | Against |
IBM | | IBM | | 459200101 | | 4/25/2017 | | S | | Special Meetings | | Yes | | Against | | For |
IBM | | IBM | | 459200101 | | 4/25/2017 | | S | | Proxy Access | | Yes | | Against | | For |
| | | | | | | | |
Pfizer | | PFE | | 717081103 | | 4/27/2017 | | M | | Directors | | Yes | | For | | For |
Pfizer | | PFE | | 717081103 | | 4/27/2017 | | M | | Accounting | | Yes | | For | | For |
Pfizer | | PFE | | 717081103 | | 4/27/2017 | | M | | Executive Compensation | | Yes | | For | | For |
Pfizer | | PFE | | 717081103 | | 4/27/2017 | | M | | Compensation Frequency | | Yes | | For | | For |
Pfizer | | PFE | | 717081103 | | 4/27/2017 | | S | | Holy Land Principals | | Yes | | Against | | For |
Pfizer | | PFE | | 717081103 | | 4/27/2017 | | S | | Shareholder Meetings | | Yes | | Against | | For |
Pfizer | | PFE | | 717081103 | | 4/27/2017 | | S | | Independent Chair | | Yes | | Against | | For |
| | | | | | | | |
Nextera | | NEE | | 65339F101 | | 5/18/2017 | | M | | Directors | | Yes | | For | | For |
Nextera | | NEE | | 65339F101 | | 5/18/2017 | | M | | Auditors | | Yes | | For | | For |
Nextera | | NEE | | 65339F101 | | 5/18/2017 | | M | | Compensation Frequency | | Yes | | For | | For |
Nextera | | NEE | | 65339F101 | | 5/18/2017 | | M | | Compensation | | Yes | | For | | For |
Nextera | | NEE | | 65339F101 | | 5/18/2017 | | M | | Stock Plan | | Yes | | For | | For |
Nextera | | NEE | | 65339F101 | | 5/18/2017 | | S | | Political Contributions | | Yes | | For | | Against |
| | | | | | | | |
Allstate | | ALL | | 020002101 | | 5/25/2017 | | M | | Directors | | Yes | | For | | For |
Allstate | | ALL | | 020002101 | | 5/25/2017 | | M | | Auditors | | Yes | | For | | For |
Allstate | | ALL | | 020002101 | | 5/25/2017 | | M | | Compensation | | Yes | | For | | For |
Allstate | | ALL | | 020002101 | | 5/25/2017 | | M | | Compensation Frequency | | Yes | | For | | For |
Allstate | | ALL | | 020002101 | | 5/25/2017 | | M | | Incentive Compensation | | Yes | | For | | For |
Allstate | | ALL | | 020002101 | | 5/25/2017 | | S | | Independent chairman | | Yes | | Against | | For |
Allstate | | ALL | | 020002101 | | 5/25/2017 | | S | | Lead Director | | Yes | | Against | | For |
Allstate | | ALL | | 020002101 | | 5/25/2017 | | S | | Political Contributions | | Yes | | For | | Against |
| | | | | | | | |
Allergan | | AGN | | G0177J108 | | 5/4/2017 | | M | | Directors | | Yes | | For | | For |
Allergan | | AGN | | G0177J108 | | 5/4/2017 | | M | | Compensation | | Yes | | For | | For |
Allergan | | AGN | | G0177J108 | | 5/4/2017 | | M | | Compensation Frequency | | Yes | | For | | For |
| | | | | | | | | | | | | | | | |
Allergan | | AGN | | G0177J108 | | 5/4/2017 | | M | | Accounting | | Yes | | For | | For |
Allergan | | AGN | | G0177J108 | | 5/4/2017 | | M | | Incentive Compensation | | Yes | | For | | For |
Allergan | | AGN | | G0177J108 | | 5/4/2017 | | S | | Independent Chairman | | Yes | | Against | | For |
| | | | | | | | |
Agenus | | AGEN | | 00847G705 | | 6/28/2017 | | M | | Directors | | Yes | | For | | For |
Agenus | | AGEN | | 00847G705 | | 6/28/2017 | | M | | Compensation | | Yes | | For | | For |
Agenus | | AGEN | | 00847G705 | | 6/28/2017 | | M | | Compensation Frequency | | Yes | | For | | For |
Agenus | | AGEN | | 00847G705 | | 6/28/2017 | | M | | Accounting | | Yes | | For | | For |
| | | | | | | | |
Flotek | | FTK | | 343389102 | | 4/21/2017 | | M | | Directors | | Yes | | For | | For |
Flotek | | FTK | | 343389102 | | 4/21/2017 | | M | | Auditors | | Yes | | For | | For |
Flotek | | FTK | | 343389102 | | 4/21/2017 | | M | | Compensation | | Yes | | For | | For |
| | | | | | | | |
Amerco | | UHAL | | 023586100 | | 8/25/2016 | | M | | Directors | | Yes | | Against | | Against |
Amerco | | UHAL | | 023586100 | | 8/25/2016 | | M | | Compensation | | Yes | | For | | For |
Amerco | | UHAL | | 023586100 | | 8/25/2016 | | M | | Board Actions | | Yes | | For | | For |
Amerco | | UHAL | | 023586100 | | 8/25/2016 | | M | | Accounting | | Yes | | For | | For |
| | | | | | | | |
Ashland | | ASH | | 44186104 | | 1/26/2017 | | M | | Directors | | Yes | | For | | For |
Ashland | | ASH | | 44186104 | | 1/26/2017 | | M | | Auditors | | Yes | | For | | For |
Ashland | | ASH | | 44186104 | | 1/26/2017 | | M | | Compensation | | Yes | | For | | For |
Ashland | | ASH | | 44186104 | | 1/26/2017 | | M | | Compensation Timing | | Yes | | For | | For |
| | | | | | | | |
Prothena | | PRTA | | G72800108 | | 5/17/2017 | | M | | Directors | | Yes | | For | | For |
Prothena | | PRTA | | G72800108 | | 5/17/2017 | | M | | Auditors | | Yes | | For | | For |
Prothena | | PRTA | | G72800108 | | 5/17/2017 | | M | | Compensation | | Yes | | For | | For |
Prothena | | PRTA | | G72800108 | | 5/17/2017 | | M | | Long term Incentive Plan | | Yes | | For | | For |
Prothena | | PRTA | | G72800108 | | 5/17/2017 | | M | | Issue Shares | | Yes | | For | | For |
Prothena | | PRTA | | G72800108 | | 5/17/2017 | | M | | Shares for cash | | Yes | | For | | For |
Prothena | | PRTA | | G72800108 | | 5/17/2017 | | M | | Motion to Adjourn | | Yes | | For | | For |
| | | | | | | | |
Durect | | DRRX | | 266605104 | | 6/19/2017 | | M | | Directors | | Yes | | For | | For |
Durect | | DRRX | | 266605104 | | 6/19/2017 | | M | | Auditors | | Yes | | For | | For |
Durect | | DRRX | | 266605104 | | 6/19/2017 | | M | | Compensation | | Yes | | For | | For |
Durect | | DRRX | | 266605104 | | 6/19/2017 | | M | | Compensation Frequency | | Yes | | For | | For |
Durect | | DRRX | | 266605104 | | 6/19/2017 | | M | | Share increase | | Yes | | For | | For |
| | | | | | | | |
Abbott | | ABT | | 002824100 | | 4/28/2017 | | M | | Directors | | Yes | | For | | For |
Abbott | | ABT | | 002824100 | | 4/28/2017 | | M | | Say on Pay | | Yes | | For | | For |
| | | | | | | | | | | | | | | | |
Abbott | | ABT | | 002824100 | | 4/28/2017 | | M | | Accounting | | Yes | | For | | For |
Abbott | | ABT | | 002824100 | | 4/28/2017 | | M | | Pay Frequency | | Yes | | For | | For |
Abbott | | ABT | | 002824100 | | 4/28/2017 | | M | | Incentive Stock | | Yes | | For | | For |
Abbott | | ABT | | 002824100 | | 4/28/2017 | | M | | Stock Purchase Plan | | Yes | | For | | For |
Abbott | | ABT | | 002824100 | | 4/28/2017 | | S | | Independent Chairman | | Yes | | Against | | For |
| | | | | | | | |
Sirius XM Holding | | SIRI | | 82968B103 | | 5/18/2017 | | M | | Directors | | Yes | | For | | For |
Sirius XM Holding | | SIRI | | 82968B103 | | 5/18/2017 | | M | | Accounting | | Yes | | For | | For |
Sirius XM Holding | | SIRI | | 82968B103 | | 5/18/2017 | | M | | Compensation | | Yes | | For | | For |
Sirius XM Holding | | SIRI | | 82968B103 | | 5/18/2017 | | M | | Compensation Frequency | | Yes | | For | | For |
| | | | | | | | |
Supernus | | SUPN | | 868459108 | | 6/13/2017 | | M | | Directors | | Yes | | For | | For |
Supernus | | SUPN | | 868459108 | | 6/13/2017 | | M | | Accounting | | Yes | | For | | For |
Supernus | | SUPN | | 868459108 | | 6/13/2017 | | M | | Compensation | | Yes | | For | | For |
Supernus | | SUPN | | 868459108 | | 6/13/2017 | | M | | Compensation Frequency | | Yes | | For | | For |
| | | | | | | | |
CMS Energy | | CMS | | 125896100 | | 5/5/2017 | | M | | Directors | | Yes | | For | | For |
CMS Energy | | CMS | | 125896100 | | 5/5/2017 | | M | | Auditors | | Yes | | For | | For |
CMS Energy | | CMS | | 125896100 | | 5/5/2017 | | M | | Compensation | | Yes | | For | | For |
CMS Energy | | CMS | | 125896100 | | 5/5/2017 | | M | | Compensation Frequency | | Yes | | For | | For |
CMS Energy | | CMS | | 125896100 | | 5/5/2017 | | S | | Political Contributions | | Yes | | For | | Against |
| | | | | | | | |
Avista | | AVA | | 05379B107 | | 5/11/2017 | | M | | Directors | | Yes | | For | | For |
Avista | | AVA | | 05379B107 | | 5/11/2017 | | M | | Auditors | | Yes | | For | | For |
Avista | | AVA | | 05379B107 | | 5/11/2017 | | M | | Compensation | | Yes | | For | | For |
Avista | | AVA | | 05379B107 | | 5/11/2017 | | M | | Compensation Frequency | | Yes | | For | | For |
Avista | | AVA | | 05379B107 | | 5/11/2017 | | M | | Approval requirements | | Yes | | For | | For |
| | | | | | | | |
Solitario | | XPL | | 8342EP107 | | 6/29/2017 | | M | | Directors | | Yes | | For | | For |
Solitario | | XPL | | 8342EP107 | | 6/29/2017 | | M | | Auditors | | Yes | | For | | For |
Solitario | | XPL | | 8342EP107 | | 6/29/2017 | | M | | Compensation | | Yes | | For | | For |
Solitario | | XPL | | 8342EP107 | | 6/29/2017 | | M | | Incentive Plan | | Yes | | For | | For |
Solitario | | XPL | | 8342EP107 | | 6/29/2017 | | M | | Name Change | | Yes | | For | | For |
Solitario | | XPL | | 8342EP107 | | 6/29/2017 | | M | | Share Issuance | | Yes | | For | | For |
| | | | | | | | |
WEC Energy | | CMS | | 976657106 | | 5/4/2017 | | M | | Directors | | Yes | | For | | For |
WEC Energy | | CMS | | 976657106 | | 5/4/2017 | | M | | Auditors | | Yes | | For | | For |
WEC Energy | | CMS | | 976657106 | | 5/4/2017 | | M | | Compensation | | Yes | | For | | For |
| | | | | | | | | | | | | | | | |
WEC Energy | | CMS | | 976657106 | | 5/4/2017 | | M | | Compensation Frequency | | Yes | | For | | For |
| | | | | | | | |
XCEL Energy | | XEL | | 98389B100 | | 5/17/2017 | | M | | Directors | | Yes | | For | | For |
XCEL Energy | | XEL | | 98389B100 | | 5/17/2017 | | M | | Auditors | | Yes | | For | | For |
XCEL Energy | | XEL | | 98389B100 | | 5/17/2017 | | M | | Compensation | | Yes | | For | | For |
XCEL Energy | | XEL | | 98389B100 | | 5/17/2017 | | M | | Compensation Frequency | | Yes | | For | | For |
XCEL Energy | | XEL | | 98389B100 | | 5/17/2017 | | S | | Role seperation | | Yes | | Against | | For |
| | | | | | | | |
Petroquest | | PQ | | 716748108 | | 5/16/2017 | | M | | Directors | | Yes | | For | | For |
Petroquest | | PQ | | 716748108 | | 5/16/2017 | | M | | Auditors | | Yes | | For | | For |
Petroquest | | PQ | | 716748108 | | 5/16/2017 | | M | | Compensation | | Yes | | For | | For |
Petroquest | | PQ | | 716748108 | | 5/16/2017 | | M | | Compensation Frequency | | Yes | | For | | For |
| | | | | | | | |
General Motors | | GM | | 37045V100 | | 6/6/2017 | | M | | Directors | | Yes | | For | | For |
General Motors | | GM | | 37045V100 | | 6/6/2017 | | M | | Auditors | | Yes | | For | | For |
General Motors | | GM | | 37045V100 | | 6/6/2017 | | M | | Compensation | | Yes | | For | | For |
General Motors | | GM | | 37045V100 | | 6/6/2017 | | M | | Long-Term Incentive Plan | | Yes | | For | | For |
General Motors | | GM | | 37045V100 | | 6/6/2017 | | S | | Independent Chairman | | Yes | | Against | | For |
General Motors | | GM | | 37045V100 | | 6/6/2017 | | S | | Dual-Class Common | | Yes | | Against | | For |
| | | | | | | | |
GEVO | | GEVO | | 374396307 | | 6/15/2017 | | M | | Directors | | Yes | | For | | For |
GEVO | | GEVO | | 374396307 | | 6/15/2017 | | M | | Common Stock Issuance | | Yes | | For | | For |
GEVO | | GEVO | | 374396307 | | 6/15/2017 | | M | | Auditors | | Yes | | For | | For |
GEVO | | GEVO | | 374396307 | | 6/15/2017 | | M | | Compensation | | Yes | | For | | For |
GEVO | | GEVO | | 374396307 | | 6/15/2017 | | M | | Compensation Frequency | | Yes | | For | | For |
SIGNATURES
Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | |
Bruce Fund, Inc. |
| |
By: | | /s/ Robert B. Bruce |
| | Robert B. Bruce, President |
|
Date: 8-21-17 |